This post discusses recent fines imposed on pharmaceutical companies for pay-for-delay agreements and examines their impact on market competition and drug pricing. It analyses regulatory measures and the ongoing debate over the balance between innovation and consumer interests.
Read more about Restricting ‘Pay-for-Delay’ AgreementsTag: Pharmaceutical Industry
Pharma Patent Search – A Challenging Task
Pharma patent search is a complex task due to the dense patent landscape and commonality of incremental innovations. This post details a structured approach to conducting thorough pharmaceutical prior art searches, highlighting the specific challenges faced by patent analysts.
Read more about Pharma Patent Search – A Challenging TaskA Pharmaceutical Perspective by Ms. Vinita Radhakrishnan
Ms. Vinita Radhakrishnan examines trade secrets and patents in the pharmaceutical sector, highlighting key IP strategies and industry trends. The analysis offers insights into current practices and future directions within pharma intellectual property.
Read more about A Pharmaceutical Perspective by Ms. Vinita RadhakrishnanPharmaceutical Business Strategy – A Generics Perspective
This article examines the strategy of generic drug companies in challenging pharmaceutical patents, focusing on Paragraph IV certifications and related litigation. It highlights trends, success rates, and the increasing participation of Indian companies in the US generics market.
Read more about Pharmaceutical Business Strategy – A Generics PerspectiveEU Trademark law threatens Indian Generic Export Market
The EU’s revised trademark law empowers customs to seize in-transit goods, raising serious concerns for Indian generic pharmaceutical exports. This development challenges established principles of territorial trademark enforcement and threatens global access to affordable medicines.
Read more about EU Trademark law threatens Indian Generic Export Market